Report Detail
Global Totally Implantable Venous Access Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4734143 |
- 24 August, 2026 |
- Global |
- 117 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Totally Implantable Venous Access Devices market size was valued at US$ 597 million in 2025 and is forecast to a readjusted size of US$ 731 million by 2032 with a CAGR of 2.9% during review period.
Totally Implantable Venous Access Devices (TIVADs), also known as implantable ports or port-a-caths, are medical devices surgically placed under the skin to provide long-term venous access. These devices consist of a small reservoir (port) connected to a catheter that is inserted into a large vein, typically the superior vena cava. TIVADs are commonly used for patients requiring frequent intravenous treatments such as chemotherapy, long-term antibiotic therapy, or parenteral nutrition. Their fully implanted design reduces the risk of infection and allows patients to maintain a better quality of life compared to external venous catheters.In 2025, global Totally Implantable Venous Access Devices production reached approximately 2.36 million Units and the price is about 250 USD/unit. The average gross profit margin of this product is 62%.
Totally Implantable Venous Access Devices (TIVADs), often referred to as implantable venous ports/PORTs, are long-term central venous access systems in which a reservoir with a puncturable septum is placed completely under the skin and connected to a central vein via a catheter. They enable repeated, reliable venous access for chronic or cyclic therapies while reducing the burden of repeated peripheral cannulation. Their clinical and economic value, however, is fundamentally dependent on proper implantation, aseptic maintenance, early complication recognition, and end-to-end vascular access governance—principles repeatedly emphasized in IV therapy and catheter infection-prevention standards. As oncology regimens, long-course anti-infectives, parenteral nutrition, and complex infusion pathways become increasingly standardized and protocol-driven, the need for durable, repeatable, and complication-manageable access grows accordingly. In parallel, hospitals are strengthening medication safety and infection-prevention programs, pulling TIVADs into broader “vascular access management” solution frameworks rather than treating them as standalone devices. This direction is consistent with how leading medtech companies describe demand tailwinds around vascular access and medication delivery portfolios in their annual reporting. The core barrier is not clinical relevance but operational reliability at scale: outcomes are highly sensitive to training, maximal barrier precautions, skin antisepsis discipline, standardized supplies, and patient follow-up adherence. When these steps are compromised, risks such as occlusion, infection, thrombosis, and pocket-related issues can escalate and directly affect hospital quality metrics and patient experience. Meanwhile, staffing constraints and government-led cost-containment initiatives create sustained pressure on pricing, forcing differentiation to shift toward evidence, service capability, and total cost of ownership rather than device claims alone. Demand is moving from “device usage” toward “lifecycle management.” Providers increasingly prioritize bundle-based infection prevention, standardized maintenance kits, connector disinfection discipline, and traceable quality programs aligned with guideline recommendations. At the same time, site-of-care shifts toward ambulatory and outpatient settings amplify the appeal of fully implanted systems—yet they also raise expectations for training, patient education, follow-up workflows, and data-enabled quality control as part of commercialization. Ongoing guideline emphasis on intravascular catheter infection prevention will continue to reinforce these downstream requirements. TIVAD material selection is a multi-objective engineering task balancing long-term biocompatibility, puncture reseal performance, imaging visibility, and connection integrity. Port bodies commonly use titanium alloys or high-performance polymers; septa typically rely on medical-grade silicone elastomers for repeated puncture resilience; and catheters often use polyurethane or silicone to balance flexibility, kink resistance, and hemocompatibility—frequently augmented by antimicrobial and anti-thrombogenic surface technologies to reduce infection and thrombus risks. The upstream “moat” extends beyond raw resin or metal supply into surface modification know-how, joining consistency, sterilization validation, and end-to-end traceable quality systems—capabilities that ultimately determine scalable compliance and clinical performance.
This report is a detailed and comprehensive analysis for global Totally Implantable Venous Access Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Totally Implantable Venous Access Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Totally Implantable Venous Access Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Totally Implantable Venous Access Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Totally Implantable Venous Access Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Totally Implantable Venous Access Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Totally Implantable Venous Access Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, AngioDynamics, ICU Medical, B. Braun, PFM Medical, Vygon, Districlass, PakuMed, Linhua Medical, Fresenius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Totally Implantable Venous Access Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Titanium Implantable Port
Plastic Implantable Port
Market segment by Venous Access Route
Internal Jugular Approach
Subclavian Approach
Other
Market segment by Lumen
Single-lumen
Dual-lumen
Multi-lumen
Market segment by Application
Intravenous Chemotherapy
Nutritional Support Therapy
Major players covered
BD
AngioDynamics
ICU Medical
B. Braun
PFM Medical
Vygon
Districlass
PakuMed
Linhua Medical
Fresenius
Sophysa
Baxter
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Totally Implantable Venous Access Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Totally Implantable Venous Access Devices, with price, sales quantity, revenue, and global market share of Totally Implantable Venous Access Devices from 2021 to 2026.
Chapter 3, the Totally Implantable Venous Access Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Totally Implantable Venous Access Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Totally Implantable Venous Access Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Totally Implantable Venous Access Devices.
Chapter 14 and 15, to describe Totally Implantable Venous Access Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Totally Implantable Venous Access Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Titanium Implantable Port
- 1.3.3 Plastic Implantable Port
- 1.4 Market Analysis by Venous Access Route
- 1.4.1 Overview: Global Totally Implantable Venous Access Devices Consumption Value by Venous Access Route: 2021 Versus 2025 Versus 2032
- 1.4.2 Internal Jugular Approach
- 1.4.3 Subclavian Approach
- 1.4.4 Other
- 1.5 Market Analysis by Lumen
- 1.5.1 Overview: Global Totally Implantable Venous Access Devices Consumption Value by Lumen: 2021 Versus 2025 Versus 2032
- 1.5.2 Single-lumen
- 1.5.3 Dual-lumen
- 1.5.4 Multi-lumen
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Totally Implantable Venous Access Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Intravenous Chemotherapy
- 1.6.3 Nutritional Support Therapy
- 1.7 Global Totally Implantable Venous Access Devices Market Size & Forecast
- 1.7.1 Global Totally Implantable Venous Access Devices Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Totally Implantable Venous Access Devices Sales Quantity (2021-2032)
- 1.7.3 Global Totally Implantable Venous Access Devices Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 BD
- 2.1.1 BD Details
- 2.1.2 BD Major Business
- 2.1.3 BD Totally Implantable Venous Access Devices Product and Services
- 2.1.4 BD Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 BD Recent Developments/Updates
- 2.2 AngioDynamics
- 2.2.1 AngioDynamics Details
- 2.2.2 AngioDynamics Major Business
- 2.2.3 AngioDynamics Totally Implantable Venous Access Devices Product and Services
- 2.2.4 AngioDynamics Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 AngioDynamics Recent Developments/Updates
- 2.3 ICU Medical
- 2.3.1 ICU Medical Details
- 2.3.2 ICU Medical Major Business
- 2.3.3 ICU Medical Totally Implantable Venous Access Devices Product and Services
- 2.3.4 ICU Medical Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 ICU Medical Recent Developments/Updates
- 2.4 B. Braun
- 2.4.1 B. Braun Details
- 2.4.2 B. Braun Major Business
- 2.4.3 B. Braun Totally Implantable Venous Access Devices Product and Services
- 2.4.4 B. Braun Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 B. Braun Recent Developments/Updates
- 2.5 PFM Medical
- 2.5.1 PFM Medical Details
- 2.5.2 PFM Medical Major Business
- 2.5.3 PFM Medical Totally Implantable Venous Access Devices Product and Services
- 2.5.4 PFM Medical Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 PFM Medical Recent Developments/Updates
- 2.6 Vygon
- 2.6.1 Vygon Details
- 2.6.2 Vygon Major Business
- 2.6.3 Vygon Totally Implantable Venous Access Devices Product and Services
- 2.6.4 Vygon Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Vygon Recent Developments/Updates
- 2.7 Districlass
- 2.7.1 Districlass Details
- 2.7.2 Districlass Major Business
- 2.7.3 Districlass Totally Implantable Venous Access Devices Product and Services
- 2.7.4 Districlass Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Districlass Recent Developments/Updates
- 2.8 PakuMed
- 2.8.1 PakuMed Details
- 2.8.2 PakuMed Major Business
- 2.8.3 PakuMed Totally Implantable Venous Access Devices Product and Services
- 2.8.4 PakuMed Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 PakuMed Recent Developments/Updates
- 2.9 Linhua Medical
- 2.9.1 Linhua Medical Details
- 2.9.2 Linhua Medical Major Business
- 2.9.3 Linhua Medical Totally Implantable Venous Access Devices Product and Services
- 2.9.4 Linhua Medical Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Linhua Medical Recent Developments/Updates
- 2.10 Fresenius
- 2.10.1 Fresenius Details
- 2.10.2 Fresenius Major Business
- 2.10.3 Fresenius Totally Implantable Venous Access Devices Product and Services
- 2.10.4 Fresenius Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Fresenius Recent Developments/Updates
- 2.11 Sophysa
- 2.11.1 Sophysa Details
- 2.11.2 Sophysa Major Business
- 2.11.3 Sophysa Totally Implantable Venous Access Devices Product and Services
- 2.11.4 Sophysa Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Sophysa Recent Developments/Updates
- 2.12 Baxter
- 2.12.1 Baxter Details
- 2.12.2 Baxter Major Business
- 2.12.3 Baxter Totally Implantable Venous Access Devices Product and Services
- 2.12.4 Baxter Totally Implantable Venous Access Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Baxter Recent Developments/Updates
3 Competitive Environment: Totally Implantable Venous Access Devices by Manufacturer
- 3.1 Global Totally Implantable Venous Access Devices Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Totally Implantable Venous Access Devices Revenue by Manufacturer (2021-2026)
- 3.3 Global Totally Implantable Venous Access Devices Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Totally Implantable Venous Access Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Totally Implantable Venous Access Devices Manufacturer Market Share in 2025
- 3.4.3 Top 6 Totally Implantable Venous Access Devices Manufacturer Market Share in 2025
- 3.5 Totally Implantable Venous Access Devices Market: Overall Company Footprint Analysis
- 3.5.1 Totally Implantable Venous Access Devices Market: Region Footprint
- 3.5.2 Totally Implantable Venous Access Devices Market: Company Product Type Footprint
- 3.5.3 Totally Implantable Venous Access Devices Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Totally Implantable Venous Access Devices Market Size by Region
- 4.1.1 Global Totally Implantable Venous Access Devices Sales Quantity by Region (2021-2032)
- 4.1.2 Global Totally Implantable Venous Access Devices Consumption Value by Region (2021-2032)
- 4.1.3 Global Totally Implantable Venous Access Devices Average Price by Region (2021-2032)
- 4.2 North America Totally Implantable Venous Access Devices Consumption Value (2021-2032)
- 4.3 Europe Totally Implantable Venous Access Devices Consumption Value (2021-2032)
- 4.4 Asia-Pacific Totally Implantable Venous Access Devices Consumption Value (2021-2032)
- 4.5 South America Totally Implantable Venous Access Devices Consumption Value (2021-2032)
- 4.6 Middle East & Africa Totally Implantable Venous Access Devices Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 5.2 Global Totally Implantable Venous Access Devices Consumption Value by Type (2021-2032)
- 5.3 Global Totally Implantable Venous Access Devices Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 6.2 Global Totally Implantable Venous Access Devices Consumption Value by Application (2021-2032)
- 6.3 Global Totally Implantable Venous Access Devices Average Price by Application (2021-2032)
7 North America
- 7.1 North America Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 7.2 North America Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 7.3 North America Totally Implantable Venous Access Devices Market Size by Country
- 7.3.1 North America Totally Implantable Venous Access Devices Sales Quantity by Country (2021-2032)
- 7.3.2 North America Totally Implantable Venous Access Devices Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 8.2 Europe Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 8.3 Europe Totally Implantable Venous Access Devices Market Size by Country
- 8.3.1 Europe Totally Implantable Venous Access Devices Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Totally Implantable Venous Access Devices Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Totally Implantable Venous Access Devices Market Size by Region
- 9.3.1 Asia-Pacific Totally Implantable Venous Access Devices Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Totally Implantable Venous Access Devices Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 10.2 South America Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 10.3 South America Totally Implantable Venous Access Devices Market Size by Country
- 10.3.1 South America Totally Implantable Venous Access Devices Sales Quantity by Country (2021-2032)
- 10.3.2 South America Totally Implantable Venous Access Devices Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Totally Implantable Venous Access Devices Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Totally Implantable Venous Access Devices Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Totally Implantable Venous Access Devices Market Size by Country
- 11.3.1 Middle East & Africa Totally Implantable Venous Access Devices Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Totally Implantable Venous Access Devices Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Totally Implantable Venous Access Devices Market Drivers
- 12.2 Totally Implantable Venous Access Devices Market Restraints
- 12.3 Totally Implantable Venous Access Devices Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Totally Implantable Venous Access Devices and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Totally Implantable Venous Access Devices
- 13.3 Totally Implantable Venous Access Devices Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Totally Implantable Venous Access Devices Typical Distributors
- 14.3 Totally Implantable Venous Access Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Totally Implantable Venous Access Devices. Industry analysis & Market Report on Totally Implantable Venous Access Devices is a syndicated market report, published as Global Totally Implantable Venous Access Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Totally Implantable Venous Access Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
